Abstract
Protein folding — the process by which polypeptide chains attain functional three‑dimensional structures — is fundamental to all cellular processes. However, errors in this process, termed protein misfolding, are implicated in the pathogenesis of a wide range of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), and prion diseases. These disorders share a common hallmark: the aberrant accumulation of misfolded proteins that aggregate into toxic oligomers and insoluble fibrils, disrupting neuronal integrity and leading to progressive cognitive and motor decline. Biophysical mechanisms that govern folding and misfolding involve complex energy landscapes, thermodynamic stability, and proteostasis network dysfunctions. Recent studies reveal that misfolded proteins can propagate via seeding and prion‑like mechanisms, amplifying pathological aggregates throughout the nervous system. This review examines the molecular basis of protein folding and misfolding, the pathophysiological roles of protein aggregates in neurodegenerative diseases, and current and emerging therapeutic strategies aimed at mitigating misfolding and aggregation.
References
1. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2006.
2. Protein folding and misfolding in neurodegenerative disorders: a review. PubMed. 2014.
3. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018.
4. Protein misfolding and aggregation in neurodegenerative diseases: pathogeneses and strategies. PubMed. 2019.
5. Creutzfeldt–Jakob disease overview. Wikipedia. 2025.
6. Structural characterization of protein folding pathways and misfolding mechanisms. J Mol Sci. 2023.